Cervical Cancer Incidence in Young U.S. Females After Human Papillomavirus Vaccine Introduction.

[1]  C. Dehlendorff,et al.  Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program , 2014, Cancer Causes & Control.

[2]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[3]  E. Unger,et al.  Population‐based trends in high‐grade cervical lesions in the early human papillomavirus vaccine era in the United States , 2015, Cancer.

[4]  E. Meites,et al.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. , 2016, MMWR. Morbidity and mortality weekly report.

[5]  Kate Soldan,et al.  Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis , 2015, BDJ.

[6]  ACOG Practice Bulletin no. 109: Cervical cytology screening. , 2009, Obstetrics and gynecology.

[7]  S. Stokley,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[8]  P. Sasieni,et al.  Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? , 2016, International journal of cancer.

[9]  Daron G Ferris,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.

[10]  M. Schiffman,et al.  Trends in cervical cancer incidence in younger US women from 2000 to 2013. , 2017, Gynecologic oncology.

[11]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[12]  A. Moscicki,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2002, CA: a cancer journal for clinicians.

[13]  J. Macneil,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015. , 2016, MMWR. Morbidity and mortality weekly report.

[14]  T. May,et al.  Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines? , 2016, Journal of women's health.

[15]  E. Kliewer,et al.  Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  V. Resto,et al.  Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old). , 2017, Vaccine.

[17]  Xavier Castellsagué,et al.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. , 2006, Journal of the National Cancer Institute.

[18]  Greta M. Massetti,et al.  Vital Signs: Cervical Cancer Incidence, Mortality, and Screening — United States, 2007–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[19]  Mahbubur Rahman,et al.  Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012. , 2016, The Journal of infectious diseases.

[20]  J. Gargano,et al.  Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014 , 2017, The Journal of infectious diseases.

[21]  E. Unger,et al.  Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012. , 2015, Vaccine.

[22]  H. Cubie,et al.  Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland , 2014, British Journal of Cancer.

[23]  F. X. Bosch,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions , 2007 .

[24]  E. Unger,et al.  Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. , 2013, The Journal of infectious diseases.

[25]  F. Guo,et al.  Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20–26 years) , 2015, Human vaccines & immunotherapeutics.

[26]  Edson Duarte Moreira Júnior,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. , 2007, The New England journal of medicine.

[27]  Elizabeth A Torrone,et al.  Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014. , 2016, American journal of public health.

[28]  J. Cuzick,et al.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. , 2015, The New England journal of medicine.

[29]  M. Sherman,et al.  Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000 , 2004, Cancer.

[30]  Ram C Tiwari,et al.  Efficient interval estimation for age-adjusted cancer rates , 2006, Statistical methods in medical research.

[31]  Martin Steinau,et al.  Prevalence of HPV After Introduction of the Vaccination Program in the United States , 2016, Pediatrics.

[32]  Jennifer S Lin,et al.  Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.

[33]  C. Schofield.  Sexually transmitted disease surveillance. , 1982, British medical journal.

[34]  Elizabeth R. Unger,et al.  Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices , 2015, MMWR. Morbidity and mortality weekly report.

[35]  A. Berenson,et al.  Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014. , 2017, Obstetrics and gynecology.

[36]  Masha Fridman,et al.  Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study , 2011, The Lancet.

[37]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012, CA: a cancer journal for clinicians.

[38]  ACOG Practice Bulletin Number 131: Screening for cervical cancer. , 2012, Obstetrics and gynecology.